| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 8.06 MB | Adobe PDF |
Orientador(es)
Resumo(s)
This master's thesis presents a business plan for an innovative approach to reduce postoperative
bleeding, a critical healthcare problem with health, social, and economic implications. It
proposes a preoperative supplementation of arachidonic acid (AA), microencapsulated for
improved efficacy. This strategy is based on recent research that connects higher levels of AA
to a lower risk of bleeding. It aims to improve patient outcomes and sustainably reduce healthcare
costs. The plan targets the growing healthcare market, particularly in cardiovascular care. It
contains market analysis, customer insights, a value chain overview, and financial analyses.
Descrição
Palavras-chave
Arachidonic acid Micro encapsulation Vascular surgery Biotechnology Biomedical innovation Molecular medicine Pharmaceutical sciences Hermostatic agents Pharmacokinetics Intellectual property Market access Business strategy
